Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single High Dose Letrozole for Ovulation Induction
NCT02703649Phase 4Completed
- Sponsor
- Mount Sinai Hospital
- Start
- Mar 2016
- Primary completion
- Jul 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of letrozole in polycystic ovary syndrome (PCOS) and anovulation (2 arms), sponsored by Mount Sinai Hospital. Primary endpoint: Number of follicles >15 mm at day of ovulation. Started Mar 2016; status: completed.
02
Drugs
letrozole
03
Conditions
polycystic ovary syndrome (PCOS)anovulation
Beyond the preview
Go deeper on NCT02703649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02703649.